Vasopressin receptor antagonists: a patent summary (2018-2022).
Sign Up to like & getrecommendations! Published in 2023 at "Expert opinion on therapeutic patents"
DOI: 10.1080/13543776.2023.2218546
Abstract: INTRODUCTION Arginine-vasopressin hormone (AVP) is a key regulator in many essential physiological processes. The effect of AVP is mediated through three receptors within the body, these are the G protein-coupled vasopressin receptors, namely V1a, V1b… read more here.
Keywords: receptor antagonists; vasopressin receptor; 2018 2022; antagonists patent ... See more keywords